Urolithin A Capsules: Bulk MOQ, Lead Time and Pricing

Powder first, capsule format second

Bulk urolithin A powder and finished urolithin A capsules are quoted for different scopes. The powder is a raw material: a grade, a specification, a lot number and a certificate of analysis. A capsule is a converted good — the same powder, plus any excipients, a shell, a fill weight, a bottle, a label and a finished-goods release. A per-kilogram figure and a per-bottle figure cannot be ranked against each other until you normalise what each one includes.

That gives the buying sequence. First approve the grade and the specification on the urolithin A product page. Second calculate what the order must physically produce, in kilograms or in capsules. Third agree which documents must exist before the first deposit. The order minimum, the price tier and the lead time are consequences of those three answers, not independent negotiation points — which is the argument made in the cosmetic raw material buying guide.

Most disagreements in this category come from a quotation that quietly covers a different scope than the buyer assumed: powder only, powder plus filling, or a full private-label run with artwork and bottling.

What the specification should state

Urolithin A is a defined compound — CAS 1143-70-0, C13H8O4, 228.20 g/mol — and a usable specification treats it as one: identity by more than a single retention time, assay by a primary method plus an orthogonal confirmation, and the physical and microbiological limits that decide whether the powder can be handled.

Read that table as the shape of a specification, not as a result. A data sheet states limits; a batch certificate states measured values against those limits for one lot. The two documents answer different questions, which is why a supplier should be able to send both — the difference is set out in COA, SDS and TDS: what each document proves and, more bluntly, in why a certificate of analysis can mislead.

Two entries in the table carry more commercial weight than the rest. Assay is the number buyers quote at each other, but a second identity method is what separates a 98% area percentage from 98% urolithin A. Density is the number nobody asks about until a filling trial fails.

Density, fill weight and whether the powder actually runs

A published bulk density of at least 0.5 g/mL and a tapped density of at least 0.6 g/mL describe a powder that can be metered. Below that band, a high-speed encapsulator fights the material: fill weights drift, the machine runs slower, and the loss allowance rises. A bench sample that looks correct tells you nothing about throughput — the useful test is a filling trial on the machine that will run the commercial batch.

The arithmetic is simple and worth doing before any quotation is requested. At a 500 mg fill, one kilogram of powder fills about 2,000 capsules before losses; at a 250 mg fill the same kilogram reaches about 4,000. A 20 kg drum therefore corresponds to roughly 40,000 capsules at a 500 mg fill. Those numbers — not the drum count — are what size a first production run, and they are the reason a capsule order minimum is usually expressed in bottle counts rather than kilograms. If your formula includes excipients, the powder mass per capsule falls while the fill-weight tolerance tightens; the calculation method for that adjustment is the same one described in calculating active concentration in a finished dose.

Where urolithin A is used in a topical formula rather than a capsule, density matters less and dispersion matters more: the grade is practically insoluble in water and soluble in DMSO and ethanol, so the screening route is a dispersion and stability trial rather than a simple dissolve. Solubility and dispersion testing covers the sequence, and water-soluble versus oil-soluble actives explains why the supplied form changes which tests matter first.

Order minimums by order type

Order minimums are set by the packaging unit, the release testing and the conversion run — not by a single supplier policy. Ask which of the four order types below the quotation covers, because the same supplier may answer with a powder minimum, a capsule-count minimum, or a bottle minimum.

For the standard grade, the published urolithin A order minimum is 1 kg in a 20 kg fibre drum, which means a buyer can start with a kilogram and scale into a full drum without changing grade. That is a different proposition from a capsule run, where the minimum is usually set by the smallest packaging run the filler will schedule and the artwork approval that goes with it.

Sample terms deserve their own line in the file. Confirm whether the sample carries the same specification as the commercial grade, whether the same production lot will supply the first order, and what happens if the delivered material differs from the approved sample. Cosmetic raw material sample evaluation and quotation sets out how to keep that record in a form that survives a dispute.

What drives the price per kilogram

Urolithin A is quoted per kilogram, and the number moves with six variables: the assay basis and how it is established, the scope of testing included, the volume band, the packaging, the delivery term and the payment terms. Two quotations that differ by thirty percent are usually not describing the same package — most often one of them excludes independent testing, or prices a smaller volume band, or delivers on a term that leaves duty and clearance with the buyer.

Ask how the volume tier is triggered — per order, per year, or per release against a forecast — and whether the discount applies to the powder, the packaging and the conversion separately. A tier that reduces only the material line while packaging stays flat is a smaller saving than it appears.

Capsule pricing is not comparable with powder pricing, because the capsule price carries fill, shell, bottling, labelling, finished-goods release and freight. A 500 mg capsule is not 500 mg of powder plus nothing: check the formula, the excipient load and the declared capsule count before converting a capsule price back to a per-kilogram equivalent. The costs that most often sit outside a headline price are independent testing, expedited production, custom packaging, delivered-duty surcharges, storage beyond the agreed free period, and re-testing after a specification change.

Lead time, scheduling and delivery terms

Lead time is a chain, not a number. Break the quotation into the stages below and ask for the breakdown in writing before the deposit — the sum of the stages is what you plan against, and the production date is not the ship date.

Custom capsule and private-label runs add two stages that powder orders never see: artwork approval and bottling. Both have their own queues, and both must clear before the run can start — which is why a private-label timeline built from a powder lead time is always optimistic.

The delivery term matters as much as the transit time. Under an ex-works or FOB arrangement the buyer carries freight, insurance, duty and clearance delay; under a delivered-duty-paid term the seller does. Neither is better in the abstract, but the comparison is only honest if both quotations use the same term. The site's terms of trade set out the baseline rawess works from, and the quality programme describes what travels with a shipment regardless of term.

Packaging, storage and stability planning

Powder ships in fibre drums with a food-grade inner liner, or in foil bags with desiccant for smaller quantities. Capsules need high-density polyethylene bottles, a closure appropriate to the market, an induction seal where the label claims one, and cartons that survive the transit. For each, confirm the minimum bottle count, whether desiccant or oxygen absorbers are included, whether label approval is digital, and which storage conditions the supplier has validated rather than assumed.

Urolithin A is a light yellow powder that is practically insoluble in water. Keep the drum sealed, away from light and moisture, and use the retest date on the certificate rather than a general rule. If the material will be held for more than a season before conversion, plan a stability review of the finished dose rather than of the powder alone — the sequence is described in cosmetic ingredient storage and stability.

Supplier vetting: documents, independence and traceability

Vetting is a document exercise with one physical check at the end. The documents establish what the supplier claims; the sample establishes whether the claim survives your own bench. Neither replaces the other, and a supplier who is unwilling to provide the first should not be asked for the second.

Request the specification sheet, the current batch certificate, the safety data sheet, the certificate of origin, the packaging dimensions and the written lead-time breakdown before the deposit — not after. A supplier who treats the first four as routine is telling you something useful about how the fifth will be handled.

Red flags are consistent across categories: an assay claim without a method, a certificate that cannot be tied to a lot, a lead time shorter than the production step it implies, no independent testing offered at any price, pressure toward full prepayment on a first order, an order minimum that changes between the quotation and the invoice, and a refusal to send a sample. The document library shows the format rawess uses for specifications and product guides, and the buying guide covers the review sequence in more detail.

Buying channel: what changes when you buy online

Consumer retail listings are built for single bottles and rarely carry batch-level documents; marketplaces are useful for a sample and weak on traceability, because the seller may not be the party that holds the lot record. A specialist ingredient supplier or the producer's own commercial desk is the channel that can answer a specification question and issue a certificate for the drum that ships.

Channel choice therefore determines which questions are answerable. Ask any channel two things: can you send the batch certificate for the lot that will ship, and can you confirm whether the sample and the commercial lot come from the same production record. If either answer is no, the channel can supply material but not the evidence a quality team needs in order to release it. The ingredient catalogue and the actives family page show how specifications are published for comparison.

Claims, tolerability and label wording

Urolithin A is discussed in research on mitochondrial and muscle function, and that literature is oral. Findings from oral research cannot simply be transferred to a topical product or to a capsule claim without grade-specific identity, safety and regulatory review — a caution also stated on the product page. Consumer-facing discussion of side effects is not a regulatory assessment either: tolerability and label wording are decisions for the finished-product brand, its regulatory team and its destination market.

For a buyer, the practical consequence is that claims work belongs to the finished-product file, while the raw-material file carries identity, assay, purity and safety data. Keep the two separate, and ask any supplier who offers claim language whether they can support it with a study on the delivered grade. The purchasing FAQ covers the document questions that come up most often at this stage.

RFQ checklist and the wording that saves a revision

Send the brief in writing and make each line answerable:

• Quantity — kilograms of powder or capsule count, plus the twelve-month forecast if a price tier depends on it.
• Specification — assay and the methods accepted, bulk density, moisture, and the shell type if capsules are in scope.
• Packaging — drum or foil bag, bottle count, label artwork status and approval route.
• Testing — batch certificate, independent report, heavy metals, microbiology, residual solvents.
• Commercial terms — delivery term, payment terms, order minimum and the volume band the price belongs to.
• Documents — safety data sheet, certificate of origin, sample approval record, retest date.

Ask in writing: "Please confirm whether the order minimum applies to the powder, the capsules, or the packaging run, and quote the next volume band. We require a lot-specific certificate of analysis and a written lead-time breakdown before the deposit, and confirmation that the sample and the first commercial lot share a production record."

That paragraph resolves most of the ambiguity a first quotation leaves open, and it produces a written record if the terms change later.

Frequently asked questions

Relevant ingredient specifications

Compare grades on the published specification before comparing prices. The urolithin A page carries the full specification, packaging and document request route for this grade.

• Urolithin A — bulk powder, specification and document request.
• Bakuchiol — an alternative active often evaluated in the same healthy-ageing brief.
• Niacinamide USP — a high-volume comparator for cost-per-dose arithmetic.
• Green Tea EGCG — a botanical active with its own marker and stability questions.
• Copper Peptide GHK-Cu — a peptide grade where assay and counter-ion handling decide the quotation.

Next steps and supporting guides

• Cosmetic Raw Material Buying Guide — the full purchasing sequence, from brief to release.
• Cosmetic Raw Material Sample Evaluation and Quotation — how to compare offers on equal terms.
• COA, SDS and TDS: what each document proves — which paper answers which question.
• Cosmetic Ingredient Purchasing FAQ — the questions procurement asks before signing.
• Cosmetic Ingredient PDF Library — downloadable product guides for the catalogue.

Download the urolithin A product guide · Request a lot certificate and a 1 kg sample